E6501/glomax (R) 96 microplate luiminometer
Ended Awarded
- Contract number
- HHSN26100006
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,141
Award facts
- Contract value 100% obligated
- $13,141.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded Promega Corporation a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $13,141.20 for a GLOMAX 96 Microplate Luminometer, with a completion date of February 28, 2013. This contract was awarded on January 23, 2013, with no small business set-aside designation. The work is to be performed in Madison, Wisconsin, where Promega maintains its headquarters. This BPA call represents a task order drawn against Promega's larger $10 million indefinite delivery vehicle with the National Institutes of Health's Office of Logistics and Acquisition Operations, which covers biological materials, chemicals, medical and scientific equipment, and maintenance services.
The GLOMAX luminometer is a specialized laboratory instrument used for luciferase-based assays and cellular analysis in research applications. As a global life sciences company specializing in biological research and diagnostic products, Promega is well-positioned to supply this advanced instrumentation to support the National Cancer Institute's research initiatives. The contract reflects the company's established role as a prime supplier of sophisticated laboratory equipment and consumables to federal research agencies, including multiple NIH institutes and centers conducting cancer research and translational science programs.
Quick answers
Who was awarded contract HHSN26100006?
HHSN26100006 was awarded to Promega Corporation by National Cancer Institute (National Institutes of Health) on January 23, 2013.
How much is contract HHSN26100006 worth?
The government has obligated $13,141 on HHSN26100006.
Is contract HHSN26100006 an order under another contract?
Yes. HHSN26100006 is a BPA call under HHSN263199900051808B, a blanket purchase agreement.
Was contract HHSN26100006 competed?
The extent of competition for HHSN26100006 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award